SAN DIEGO, Jan. 8, 2020 /PRNewswire/ -- Arena
Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that
Amit D. Munshi, the Company's
President and Chief Executive Officer, will present a corporate
update at the 38th Annual J.P. Morgan Healthcare
Conference on Thursday, January 16,
at 1:00 PM ET (10:00 AM PT). The conference will take place
January 13-16, 2020, at the Westin
St. Francis Hotel in San
Francisco.
A live audio webcast of the presentation will be posted
under the investor relations section of Arena's website at
www.arenapharm.com. A replay of the presentation will be available
for 30 days following the event.
About Arena Pharmaceuticals
Arena Pharmaceuticals is
uniquely positioned to develop best-in-disease medicines with
optimized efficacy and safety for patients globally. Our drive to
deliver a robust pipeline of novel, transformational medicines is
grounded in two decades of world class G-protein-coupled receptor
(GPCR) discovery research.
It is the breadth and depth of the portfolio, the prioritization
of drug development to meet unmet patient needs, the strong
financial health and the growing, bold-thinking world-class team
that gives Arena the ingredients and passion to build a
sustainable, vibrant next generation pharmaceutical company.
Forward-Looking Statements
Certain statements in this
press release are forward-looking statements that involve a number
of risks and uncertainties. Such forward-looking statements include
statements about the upcoming conference and Arena's position,
including to develop best-in-disease medicines, Arena's drive,
portfolio, prioritization, and financial position, and Arena's
team, including its growth, thinking, and ability to build the
company. For such statements, Arena claims the protection of the
Private Securities Litigation Reform Act of 1995. Actual events or
results may differ materially from Arena's expectations. Factors
that could cause actual results to differ materially from the
forward-looking statements include those disclosed in Arena's
filings with the Securities and Exchange Commission. These
forward-looking statements represent Arena's judgment as of the
time of this release. Arena disclaims any intent or obligation to
update these forward-looking statements, other than as may be
required under applicable law.
Corporate Contact:
Kevin R.
Lind
Arena Pharmaceuticals, Inc.
Executive Vice President and
Chief Financial
Officer
klind@arenapharm.com
858.210.3636
Arena Media Contact:
IR@arenapharm.com
858-453-7200
View original content to download
multimedia:http://www.prnewswire.com/news-releases/arena-pharmaceuticals-to-present-at-the-38th-annual-jp-morgan-healthcare-conference-on-january-16-300983179.html
SOURCE Arena Pharmaceuticals, Inc.